- Projects & figures
- News & Events
- Managing your project
- About ERC
A European biologist has pioneered a new way of looking at biodiversity change, with the help of the European Research Council (ERC). A key result of this work has been the launch of an open-access biodiversity database, which will help researchers and conservation managers find sustainable solutions to protect wildlife.
Humans have wondered at flight since primeval times. Yet despite almost two centuries of designing machines to fly, birds still do it better in many ways. Dr Shane Windsor, a lecturer in Aerodynamics at the University of Bristol, is looking at how birds control their flight in windy conditions with the aim to improve the engineering of small-scale unmanned air vehicles (UAVs) for use in and around urban areas.
When the engines of a plane rev up and we are momentarily plunged into our seats, chances are that propulsion is due to a gas turbine. Although these energy generators are fundamental to industry, especially to aeronautics, their production of harmful exhaust gases is a cause of concern. ERC grantee Aimee Morgans works on making gas turbines greener.
Bacteria fight big. When they meet competitors, they are as aggressive and bloodthirsty as they come. ERC grantee Kevin Foster studies how bacteria wage war against each other. His aim is to understand what led to the evolution of such extreme competitive behaviours, and how to exploit them for our own health.
“Once lost is lost", one may think, especially if the piece of forgotten patrimony is an opera from 1850 that is “incomplete, too fragmented and irretrievable”, according to the experts. Except for Dr. David Trippet: like an art restorer holding fine paintbrushes, he has dedicated three years of intensive research to retrieve the unborn opera, bringing the music and libretto back to life 170 years later.
According to the World Health Organisation (WHO), more than 1.9 billion adults were overweight in 2016. Of these, over 650 million were obese and therefore at a higher risk of developing cardiovascular diseases, diabetes, musculoskeletal disorders and some forms of cancers. In one of the largest studies of its kind, researchers have looked into the reasons why some people are more likely to gain weight while others manage to stay thin.
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancer
Pancreatic cancer is the 4th leading cause of death by cancer in Europe. It has a very low survival rate with less than 1 per cent of sufferers surviving for 10 or more years. Over the last 40 years the survival rate has not significantly changed and finding an effective therapy has become a pressing challenge in cancer research. A team based at Imperial College London led by Armando Del Río Hernández, has now demonstrated that a well-known drug could be effective to fight this deadly and other forms of cancer, such as liver cancer.
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex vivo three-dimensional organoid cultures that replicate genetic events in CRC, as tools to test novel therapeutics.
Can architects provide new types of evidence on war crimes and human rights violations? Dr Eyal Weizman believes they can. With the ERC backing, he developed a new field of research: forensic architecture. Dr Weizman and a multidisciplinary team of architects, software engineers, graphic designers and researchers provide architectural evidence and new perspectives on violent events and conflicts around the world.
The use and misuse of antibiotics has accelerated the emergence of drug-resistant bacterial strains, threatening our ability to treat common diseases. EU-funded research has shed new light on the mechanisms behind these microbial mutations, with implications for our understanding of diseases and resistance to treatment.